-transparent.png){kind=logo}
Fourteen cases of anaplastic thyroid carcinoma (ATC) treated at Baylor College of Medicine, Houston, during a 19-year period were reviewed. There was a 1.3:1 female preponderance, and the median patient age was 62 years. Ten (71%) of the anaplastic tumors either followed or occurred simultaneously with a well-differentiated thyroid carcinoma. This finding adds support to the theory that ATC usually results from the transformation of well-differentiated thyroid carcinoma. A combination of surgery, radiation therapy, and chemotherapy was utilized for most patients. In this series of patients, the median duration of survival was four months following diagnosis, with only three patients (21%) alive at one year. Despite aggressive therapy, the prognosis for ATC remains poor.
J R Spires, and
M R Schwartz, and
R H Miller
November 2007,
Nihon rinsho. Japanese journal of clinical medicine,
J R Spires, and
M R Schwartz, and
R H Miller
January 1982,
The Yale journal of biology and medicine,
J R Spires, and
M R Schwartz, and
R H Miller
February 2023,
The Laryngoscope,
J R Spires, and
M R Schwartz, and
R H Miller
January 2009,
International journal of health sciences,
J R Spires, and
M R Schwartz, and
R H Miller
March 2006,
American journal of clinical pathology,
J R Spires, and
M R Schwartz, and
R H Miller
January 1997,
Anticancer research,
J R Spires, and
M R Schwartz, and
R H Miller
April 2006,
Cancer control : journal of the Moffitt Cancer Center,
J R Spires, and
M R Schwartz, and
R H Miller
December 1993,
Endocrine pathology,
J R Spires, and
M R Schwartz, and
R H Miller
July 1987,
Histopathology,
J R Spires, and
M R Schwartz, and
R H Miller
February 2021,
Journal of applied genetics,
